Clazolam
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H17ClN2O |
Molar mass | 312.80 g·mol−1 |
3D model (JSmol) | |
SMILES
|
Clazolam[1] (SAH-1123), also referred to as isoquinazepon, is a drug which is a fused benzodiazepine and tetrahydroisoquinoline derivative.[2] It was developed in the 1960s but was never marketed.[2] It possesses anxiolytic effects and is also claimed to have antidepressant properties.[2][3]
See also
- Benzodiazepine
- Tetrahydroisoquinoline
References
- ↑ NL 6510987
- 1 2 3 Triggle DJ (1997). Dictionary of pharmacological agents. London: Chapman & Hall. p. 476. ISBN 0-412-46630-9.
- ↑ Potikha LM, Kovtunenko VA (2009). "Synthesis and properties of 3-aminodihydroisoquinolines". Russian Chemical Reviews. 78 (6): 513–533. Bibcode:2009RuCRv..78..513P. doi:10.1070/RC2009v078n06ABEH004041.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.